HEADER IMMUNOGLOBULIN 02-JUN-98 2PCP TITLE ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOGLOBULIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: FAB; COMPND 5 OTHER_DETAILS: COMPLEXED WITH 1-(1-PHENYLCYCLOHEXYL) PIPERIDINE (PCP, COMPND 6 OR PHENCYCLIDINE); COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: IMMUNOGLOBULIN; COMPND 9 CHAIN: B, D; COMPND 10 FRAGMENT: FAB; COMPND 11 OTHER_DETAILS: COMPLEXED WITH 1-(1-PHENYLCYCLOHEXYL) PIPERIDINE (PCP, COMPND 12 OR PHENCYCLIDINE) SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 7 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 8 ORGANISM_TAXID: 10090 KEYWDS IMMUNOGLOBULIN EXPDTA X-RAY DIFFRACTION AUTHOR K.LIM,S.M.OWENS,L.ARNOLD,J.C.SACCHETTINI,D.S.LINTHICUM REVDAT 3 09-AUG-23 2PCP 1 REMARK SEQADV REVDAT 2 24-FEB-09 2PCP 1 VERSN REVDAT 1 27-JAN-99 2PCP 0 JRNL AUTH K.LIM,S.M.OWENS,L.ARNOLD,J.C.SACCHETTINI,D.S.LINTHICUM JRNL TITL CRYSTAL STRUCTURE OF MONOCLONAL 6B5 FAB COMPLEXED WITH JRNL TITL 2 PHENCYCLIDINE. JRNL REF J.BIOL.CHEM. V. 273 28576 1998 JRNL REFN ISSN 0021-9258 JRNL PMID 9786848 JRNL DOI 10.1074/JBC.273.44.28576 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 78.7 REMARK 3 NUMBER OF REFLECTIONS : 31830 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.800 REMARK 3 FREE R VALUE TEST SET COUNT : 3074 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.017 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6628 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 678 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 2.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 2.100 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PCP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178449. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : AUG-97 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33694 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 79.3 REMARK 200 DATA REDUNDANCY : 2.100 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : 0.09100 REMARK 200 FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.22100 REMARK 200 R SYM FOR SHELL (I) : 0.22100 REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: PDB ENTRY 4FAB AND 1GIG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 4.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THERE ARE TWO FAB MOLECULES IN THE ASYMMETRIC UNIT. THE REMARK 300 LIGHT CHAINS ARE NAMED A AND C, AND THE HEAVY CHAINS ARE REMARK 300 NAMED B AND D. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 104 CA - CB - CG ANGL. DEV. = 15.0 DEGREES REMARK 500 LEU A 160 CA - CB - CG ANGL. DEV. = 16.2 DEGREES REMARK 500 SER A 201 N - CA - C ANGL. DEV. = -17.3 DEGREES REMARK 500 ILE A 205 N - CA - C ANGL. DEV. = -16.4 DEGREES REMARK 500 PRO B 118 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 PRO B 151 C - N - CA ANGL. DEV. = -9.0 DEGREES REMARK 500 LEU C 181 CA - CB - CG ANGL. DEV. = 14.9 DEGREES REMARK 500 LEU D 109 CA - CB - CG ANGL. DEV. = 14.8 DEGREES REMARK 500 ALA D 129 N - CA - C ANGL. DEV. = -26.0 DEGREES REMARK 500 ALA D 130 N - CA - C ANGL. DEV. = 18.1 DEGREES REMARK 500 PRO D 151 C - N - CA ANGL. DEV. = -11.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 27A 136.40 -39.60 REMARK 500 VAL A 51 -55.40 65.19 REMARK 500 ARG A 77 79.74 71.25 REMARK 500 GLU A 81 10.71 -69.00 REMARK 500 ARG A 108 -156.02 -162.91 REMARK 500 TYR A 140 138.43 176.11 REMARK 500 ILE A 144 110.05 -160.79 REMARK 500 GLN A 156 -47.21 -135.72 REMARK 500 SER A 171 30.37 76.95 REMARK 500 LYS A 183 -34.93 -36.48 REMARK 500 ARG A 188 28.08 -79.23 REMARK 500 ASN A 190 -67.72 -106.76 REMARK 500 SER A 203 125.70 -171.30 REMARK 500 VAL B 2 81.60 -60.39 REMARK 500 HIS B 41 51.15 73.70 REMARK 500 LYS B 43 -82.76 -115.58 REMARK 500 PRO B 52A 19.82 -64.97 REMARK 500 LEU B 82C 97.74 -56.00 REMARK 500 GLU B 85 -8.40 -52.20 REMARK 500 ASP B 101 -90.67 -124.14 REMARK 500 PRO B 118 161.56 -41.52 REMARK 500 PRO B 126 -102.79 -70.43 REMARK 500 SER B 128 -2.95 -154.06 REMARK 500 ALA B 129 -163.73 -118.47 REMARK 500 ALA B 130 102.37 -47.96 REMARK 500 GLN B 131 153.75 -24.85 REMARK 500 GLU B 150 -29.19 -33.08 REMARK 500 SER B 165 41.95 -89.50 REMARK 500 LEU B 166 83.84 -170.94 REMARK 500 PRO B 175 -174.58 -69.52 REMARK 500 ASP B 183 22.48 83.53 REMARK 500 PRO B 198 -97.83 -54.53 REMARK 500 ALA B 214 5.31 -48.48 REMARK 500 SER B 215 -4.37 -140.35 REMARK 500 LYS B 222 -161.97 -160.45 REMARK 500 ILE B 223 -150.85 -153.60 REMARK 500 LEU C 47 -72.26 -105.77 REMARK 500 VAL C 51 -55.87 69.31 REMARK 500 SER C 56 94.11 -63.38 REMARK 500 ARG C 77 70.83 75.34 REMARK 500 ARG C 108 -159.69 -151.22 REMARK 500 ASP C 110 137.02 -38.81 REMARK 500 TYR C 140 133.80 -178.64 REMARK 500 ASP C 143 77.35 -64.42 REMARK 500 SER C 171 47.27 70.87 REMARK 500 HIS C 198 -164.92 -100.68 REMARK 500 LYS C 199 -70.69 -93.18 REMARK 500 SER C 201 72.63 70.15 REMARK 500 THR C 202 44.90 27.91 REMARK 500 HIS D 41 73.49 61.80 REMARK 500 REMARK 500 THIS ENTRY HAS 67 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 140 0.07 SIDE CHAIN REMARK 500 TYR A 192 0.07 SIDE CHAIN REMARK 500 TYR B 50 0.07 SIDE CHAIN REMARK 500 TYR C 140 0.07 SIDE CHAIN REMARK 500 TYR D 50 0.07 SIDE CHAIN REMARK 500 TYR D 90 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1PC B 227 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1PC C 212 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FAB MOLECULES ARE NUMBERED ACCORDING TO KABAT REMARK 999 (E.A.KABAT, T.T.WU, H.M.PERRY, K.S.GOTTESMAN, AND REMARK 999 C.FOELLER, SEQUENCES OF PROTEINS OF IMMUNOLOGICAL REMARK 999 INTEREST, 1991). DBREF 2PCP A 1 211 PIR PC4203 PC4203 1 216 DBREF 2PCP C 1 211 PIR PC4203 PC4203 1 216 DBREF 2PCP B 1 226 PDB 2PCP 2PCP 1 226 DBREF 2PCP D 1 226 PDB 2PCP 2PCP 1 226 SEQADV 2PCP THR A 27A PIR PC4203 SER 28 CONFLICT SEQADV 2PCP SER A 27E PIR PC4203 THR 32 CONFLICT SEQADV 2PCP THR A 52 PIR PC4203 SER 57 CONFLICT SEQADV 2PCP THR A 92 PIR PC4203 SER 97 CONFLICT SEQADV 2PCP ALA A 94 PIR PC4203 VAL 99 CONFLICT SEQADV 2PCP TYR A 96 PIR PC4203 ARG 101 CONFLICT SEQADV 2PCP THR C 27A PIR PC4203 SER 28 CONFLICT SEQADV 2PCP SER C 27E PIR PC4203 THR 32 CONFLICT SEQADV 2PCP THR C 52 PIR PC4203 SER 57 CONFLICT SEQADV 2PCP THR C 92 PIR PC4203 SER 97 CONFLICT SEQADV 2PCP ALA C 94 PIR PC4203 VAL 99 CONFLICT SEQADV 2PCP TYR C 96 PIR PC4203 ARG 101 CONFLICT SEQRES 1 A 216 ASP VAL LEU MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 A 216 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 A 216 GLN THR ILE VAL HIS SER ASN GLY ASN THR TYR LEU GLU SEQRES 4 A 216 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 A 216 ILE TYR LYS VAL THR ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 A 216 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 A 216 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 A 216 TYR CYS PHE GLN GLY THR HIS ALA PRO TYR THR PHE GLY SEQRES 9 A 216 GLY GLY THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA SEQRES 10 A 216 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 A 216 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 A 216 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 A 216 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 A 216 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 A 216 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 A 216 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 A 216 PRO ILE VAL LYS SER PHE ASN ARG SEQRES 1 B 215 GLU VAL GLN LEU GLN GLN SER GLY PRO GLU LEU VAL LYS SEQRES 2 B 215 PRO GLY ALA SER VAL LYS MET SER CYS LYS ALA SER GLY SEQRES 3 B 215 TYR THR PHE THR ASP TYR TYR ILE HIS TRP ASN LYS GLN SEQRES 4 B 215 SER HIS GLY LYS SER LEU GLU TRP ILE GLY TYR ILE TYR SEQRES 5 B 215 PRO ASN ASN GLY GLY ASN GLY TYR ASN HIS LYS PHE LYS SEQRES 6 B 215 GLY LYS ALA THR LEU THR VAL ASP LYS SER SER SER THR SEQRES 7 B 215 ALA TYR MET ASP VAL ARG THR LEU THR SER GLU ASP SER SEQRES 8 B 215 ALA VAL TYR TYR CYS GLY ARG SER THR TRP ASP ASP PHE SEQRES 9 B 215 ASP TYR TRP GLY GLN GLY THR THR LEU THR VAL SER SER SEQRES 10 B 215 ALA LYS THR THR PRO PRO SER VAL TYR PRO LEU ALA PRO SEQRES 11 B 215 GLY SER ALA ALA GLN THR ASN SER MET VAL THR LEU GLY SEQRES 12 B 215 CYS LEU VAL LYS GLY TYR PHE PRO GLU PRO VAL THR LEU SEQRES 13 B 215 THR TRP ASN SER GLY SER LEU SER SER GLY VAL HIS THR SEQRES 14 B 215 PHE PRO ALA VAL LEU GLN SER ASP LEU TYR THR LEU SER SEQRES 15 B 215 SER SER VAL THR VAL THR SER SER PRO ARG PRO SER GLU SEQRES 16 B 215 THR VAL THR CYS ASN VAL ALA HIS PRO ALA SER SER THR SEQRES 17 B 215 LYS VAL ASP LYS LYS ILE VAL SEQRES 1 C 216 ASP VAL LEU MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 C 216 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 C 216 GLN THR ILE VAL HIS SER ASN GLY ASN THR TYR LEU GLU SEQRES 4 C 216 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 C 216 ILE TYR LYS VAL THR ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 C 216 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 C 216 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 C 216 TYR CYS PHE GLN GLY THR HIS ALA PRO TYR THR PHE GLY SEQRES 9 C 216 GLY GLY THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA SEQRES 10 C 216 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 C 216 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 C 216 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 C 216 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 C 216 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 C 216 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 C 216 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 C 216 PRO ILE VAL LYS SER PHE ASN ARG SEQRES 1 D 215 GLU VAL GLN LEU GLN GLN SER GLY PRO GLU LEU VAL LYS SEQRES 2 D 215 PRO GLY ALA SER VAL LYS MET SER CYS LYS ALA SER GLY SEQRES 3 D 215 TYR THR PHE THR ASP TYR TYR ILE HIS TRP ASN LYS GLN SEQRES 4 D 215 SER HIS GLY LYS SER LEU GLU TRP ILE GLY TYR ILE TYR SEQRES 5 D 215 PRO ASN ASN GLY GLY ASN GLY TYR ASN HIS LYS PHE LYS SEQRES 6 D 215 GLY LYS ALA THR LEU THR VAL ASP LYS SER SER SER THR SEQRES 7 D 215 ALA TYR MET ASP VAL ARG THR LEU THR SER GLU ASP SER SEQRES 8 D 215 ALA VAL TYR TYR CYS GLY ARG SER THR TRP ASP ASP PHE SEQRES 9 D 215 ASP TYR TRP GLY GLN GLY THR THR LEU THR VAL SER SER SEQRES 10 D 215 ALA LYS THR THR PRO PRO SER VAL TYR PRO LEU ALA PRO SEQRES 11 D 215 GLY SER ALA ALA GLN THR ASN SER MET VAL THR LEU GLY SEQRES 12 D 215 CYS LEU VAL LYS GLY TYR PHE PRO GLU PRO VAL THR LEU SEQRES 13 D 215 THR TRP ASN SER GLY SER LEU SER SER GLY VAL HIS THR SEQRES 14 D 215 PHE PRO ALA VAL LEU GLN SER ASP LEU TYR THR LEU SER SEQRES 15 D 215 SER SER VAL THR VAL THR SER SER PRO ARG PRO SER GLU SEQRES 16 D 215 THR VAL THR CYS ASN VAL ALA HIS PRO ALA SER SER THR SEQRES 17 D 215 LYS VAL ASP LYS LYS ILE VAL HET 1PC B 227 18 HET 1PC C 212 18 HETNAM 1PC 1-(PHENYL-1-CYCLOHEXYL)PIPERIDINE HETSYN 1PC PHENCYCLIDINE FORMUL 5 1PC 2(C17 H25 N) FORMUL 7 HOH *678(H2 O) HELIX 1 1 ALA A 80 ASP A 82 5 3 HELIX 2 2 SER A 122 SER A 127 1 6 HELIX 3 3 LYS A 183 GLU A 187 1 5 HELIX 4 4 SER B 84 ASP B 86 5 3 HELIX 5 5 ASN B 162 GLY B 164 5 3 HELIX 6 6 PRO B 213 SER B 215 5 3 HELIX 7 7 ALA C 80 ASP C 82 5 3 HELIX 8 8 SER C 122 THR C 126 1 5 HELIX 9 9 LYS C 183 ARG C 188 1 6 HELIX 10 10 SER D 84 ASP D 86 5 3 HELIX 11 11 ASN D 162 GLY D 164 5 3 SHEET 1 A 4 MET A 4 THR A 7 0 SHEET 2 A 4 GLN A 18 SER A 25 -1 N ARG A 24 O THR A 5 SHEET 3 A 4 ASP A 70 SER A 76 -1 N ILE A 75 O ALA A 19 SHEET 4 A 4 PHE A 62 SER A 67 -1 N SER A 67 O ASP A 70 SHEET 1 B 4 THR A 102 LEU A 104 0 SHEET 2 B 4 GLY A 84 GLN A 90 -1 N TYR A 86 O THR A 102 SHEET 3 B 4 LEU A 33 GLN A 38 -1 N GLN A 38 O VAL A 85 SHEET 4 B 4 PRO A 44 TYR A 49 -1 N ILE A 48 O TRP A 35 SHEET 1 C 4 THR A 114 PHE A 118 0 SHEET 2 C 4 GLY A 129 ASN A 137 -1 N ASN A 137 O THR A 114 SHEET 3 C 4 MET A 175 THR A 182 -1 N LEU A 181 O ALA A 130 SHEET 4 C 4 VAL A 159 TRP A 163 -1 N SER A 162 O SER A 176 SHEET 1 D 4 SER A 153 ARG A 155 0 SHEET 2 D 4 VAL A 146 ILE A 150 -1 N ILE A 150 O SER A 153 SHEET 3 D 4 SER A 191 ALA A 196 -1 N GLU A 195 O LYS A 147 SHEET 4 D 4 ILE A 205 ASN A 210 -1 N PHE A 209 O TYR A 192 SHEET 1 E 4 GLN B 3 GLN B 6 0 SHEET 2 E 4 SER B 17 SER B 25 -1 N SER B 25 O GLN B 3 SHEET 3 E 4 THR B 77 ARG B 82A-1 N VAL B 82 O VAL B 18 SHEET 4 E 4 ALA B 67 ASP B 72 -1 N ASP B 72 O THR B 77 SHEET 1 F 6 GLU B 10 VAL B 12 0 SHEET 2 F 6 THR B 107 VAL B 111 1 N THR B 110 O GLU B 10 SHEET 3 F 6 ALA B 88 SER B 95 -1 N TYR B 90 O THR B 107 SHEET 4 F 6 TYR B 33 SER B 40 -1 N GLN B 39 O VAL B 89 SHEET 5 F 6 SER B 44 TYR B 52 -1 N ILE B 51 O ILE B 34 SHEET 6 F 6 GLY B 56 TYR B 59 -1 N GLY B 58 O TYR B 50 SHEET 1 G 4 SER B 120 LEU B 124 0 SHEET 2 G 4 MET B 137 LYS B 145 -1 N LYS B 145 O SER B 120 SHEET 3 G 4 LEU B 187 THR B 194 -1 N VAL B 193 O VAL B 138 SHEET 4 G 4 VAL B 171 THR B 173 -1 N HIS B 172 O SER B 190 SHEET 1 H 3 THR B 153 TRP B 157 0 SHEET 2 H 3 CYS B 208 HIS B 212 -1 N ALA B 211 O THR B 153 SHEET 3 H 3 THR B 217 LYS B 221 -1 N LYS B 221 O CYS B 208 SHEET 1 I 2 VAL B 177 GLN B 179 0 SHEET 2 I 2 LEU B 184 THR B 186 -1 N THR B 186 O VAL B 177 SHEET 1 J 4 MET C 4 THR C 7 0 SHEET 2 J 4 ALA C 19 SER C 25 -1 N ARG C 24 O THR C 5 SHEET 3 J 4 ASP C 70 ILE C 75 -1 N ILE C 75 O ALA C 19 SHEET 4 J 4 PHE C 62 SER C 67 -1 N SER C 67 O ASP C 70 SHEET 1 K 5 SER C 10 SER C 14 0 SHEET 2 K 5 THR C 102 LYS C 107 1 N LYS C 103 O LEU C 11 SHEET 3 K 5 GLY C 84 GLN C 90 -1 N TYR C 86 O THR C 102 SHEET 4 K 5 LEU C 33 GLN C 38 -1 N GLN C 38 O VAL C 85 SHEET 5 K 5 LYS C 45 TYR C 49 -1 N ILE C 48 O TRP C 35 SHEET 1 L 4 THR C 114 ILE C 117 0 SHEET 2 L 4 GLY C 129 ASN C 137 -1 N ASN C 137 O THR C 114 SHEET 3 L 4 MET C 175 THR C 182 -1 N LEU C 181 O ALA C 130 SHEET 4 L 4 VAL C 159 TRP C 163 -1 N SER C 162 O SER C 176 SHEET 1 M 3 ASN C 145 ILE C 150 0 SHEET 2 M 3 SER C 191 THR C 197 -1 N THR C 197 O ASN C 145 SHEET 3 M 3 PRO C 204 ASN C 210 -1 N PHE C 209 O TYR C 192 SHEET 1 N 4 GLN D 3 GLN D 5 0 SHEET 2 N 4 VAL D 18 SER D 25 -1 N SER D 25 O GLN D 3 SHEET 3 N 4 THR D 77 VAL D 82 -1 N VAL D 82 O VAL D 18 SHEET 4 N 4 ALA D 67 ASP D 72 -1 N ASP D 72 O THR D 77 SHEET 1 O 2 GLU D 10 VAL D 12 0 SHEET 2 O 2 LEU D 109 VAL D 111 1 N THR D 110 O GLU D 10 SHEET 1 P 5 GLY D 56 TYR D 59 0 SHEET 2 P 5 LEU D 45 TYR D 52 -1 N TYR D 52 O GLY D 56 SHEET 3 P 5 TYR D 33 GLN D 39 -1 N LYS D 38 O GLU D 46 SHEET 4 P 5 VAL D 89 SER D 95 -1 N SER D 95 O TYR D 33 SHEET 5 P 5 PHE D 100 TRP D 103 -1 N TYR D 102 O ARG D 94 SHEET 1 Q 3 VAL D 121 LEU D 124 0 SHEET 2 Q 3 MET D 137 TYR D 147 -1 N LEU D 143 O TYR D 122 SHEET 3 Q 3 TYR D 185 THR D 194 -1 N VAL D 193 O VAL D 138 SHEET 1 R 2 THR D 206 HIS D 212 0 SHEET 2 R 2 THR D 217 LYS D 222 -1 N LYS D 221 O CYS D 208 SSBOND 1 CYS A 23 CYS A 88 1555 1555 2.03 SSBOND 2 CYS A 134 CYS A 194 1555 1555 2.02 SSBOND 3 CYS B 22 CYS B 92 1555 1555 2.00 SSBOND 4 CYS B 142 CYS B 208 1555 1555 1.98 SSBOND 5 CYS C 23 CYS C 88 1555 1555 2.02 SSBOND 6 CYS C 134 CYS C 194 1555 1555 2.02 SSBOND 7 CYS D 22 CYS D 92 1555 1555 2.03 SSBOND 8 CYS D 142 CYS D 208 1555 1555 2.04 CISPEP 1 THR A 7 PRO A 8 0 -0.18 CISPEP 2 ALA A 94 PRO A 95 0 0.18 CISPEP 3 TYR A 140 PRO A 141 0 0.16 CISPEP 4 PHE B 148 PRO B 149 0 -2.32 CISPEP 5 ARG B 199 PRO B 200 0 -0.06 CISPEP 6 THR C 7 PRO C 8 0 0.03 CISPEP 7 ALA C 94 PRO C 95 0 0.27 CISPEP 8 TYR C 140 PRO C 141 0 -2.27 CISPEP 9 PHE D 148 PRO D 149 0 -1.04 CISPEP 10 ARG D 199 PRO D 200 0 1.21 SITE 1 AC1 8 TYR A 32 GLY A 91 TYR A 96 HIS B 35 SITE 2 AC1 8 SER B 95 TRP B 97 ASP B 98 PHE B 100 SITE 1 AC2 9 GLY C 91 TYR C 96 TYR D 33 HIS D 35 SITE 2 AC2 9 TYR D 50 SER D 95 TRP D 97 ASP D 98 SITE 3 AC2 9 PHE D 100 CRYST1 53.460 67.720 68.040 62.11 84.66 83.17 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018706 -0.002240 -0.000804 0.00000 SCALE2 0.000000 0.014872 -0.007747 0.00000 SCALE3 0.000000 0.000000 0.016644 0.00000